Skip to main content

Table 5 Demographics and comorbidities

From: The effect of cumulative glycemic burden on the incidence of diabetic foot disease

Cohort with Charcot arthropathy vs. cohort without, diabetics only

 

No Charcot (N = 717)

Charcot (N = 54)

P value

N

%Total

N

%Total

 

Gender

     

 Female

370

51.6

26

48.1

0.624

 Male

347

48.4

28

51.9

 

Race

    

0.331

 American Indian or Alaskan Native

1

0.1

0

0

 

 Asian

23

3.2

3

5.6

 

 Black or African American

179

25

14

25.9

 

 Declined

75

10.5

8

14.8

 

 Hispanic

7

1

0

0

 

 Native Hawaiian or other Pacific Islander

1

0.1

1

1.9

 

 Other

96

13.4

8

14.8

 

 Unknown

29

4

2

3.7

 

 White

306

42.7

18

33.3

 

Smoking

255

38.1

21

39.6

0.828

Diabetic nephropathy

62

8.6

2

3.7

0.204

Diabetic retinopathy

96

13.4

5

9.3

0.386

Diabetic neuropathy

76

15.7

7

20

0.103

Hypertension

505

70.4

43

79.6

0.151

Peripheral vascular disease

62

8.6

4

7.4

0.754

Coronary artery disease

180

25.1

16

29.6

0.461

Chronic kidney disease

128

17.9

9

16.7

0.826

Age, year

61 (14)

 

57 (14)

 

0.087

BMI

31.7 (7.9)

 

31.8 (8.7)

 

0.301

Mean number of HgA1c values drawn

7 (6)

 

8 (6)

 

0.512

HgA1c, mean

6.7 (1.5)

 

6.5 (1.4)

 

0.401

  1. Significance defined as P < .05. Continuous variables expressed as mean (standard deviation)